Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Folge dem Geld: Methan im Fokus der COP31!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 548183 | ISIN: HK1093012172 | Ticker: CVG
Stuttgart
18.11.26 | 21:56
0,901 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Hong Kong 50
1-Jahres-Chart
CSPC PHARMACEUTICAL GROUP LTD Chart 1 Jahr
5-Tage-Chart
CSPC PHARMACEUTICAL GROUP LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,9050,94118.11.
0,9000,92918.11.

Aktuelle News zur CSPC PHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiCSPC Pharmaceutical Group Ltd. Announces Rise In Nine Months Bottom Line5
MiCSPC PHARMA 1-3Q Net Profit RMB7.076B Up 101.5%4
MiCSPC PHARMA (01093): UNAUDITED CONSOLIDATED RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 20265
DiCSPC PHARMA Starts Phase Ib/II Clinical Trial in China for SYH2051 Combined With Irinotecan Liposome for Advanced Solid Tumors5
MoCSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - PHASE IB/II CLINICAL TRIAL OF SYH2051 IN COMBINATION WITH IRINOTECAN LIPOSOME FOR THE TREATMENT OF ADVANCED ...2
10.11.Dividendenbekanntmachungen (10.11.2026)7.271 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  AGNC INVESTMENT CORP  US00123Q1040  0,12 USD   EUR  AMBRA SA  PLAMBRA00013  1,1 PLN   EUR  AMERICA MOVIL SAB DE CV  MX01AM050019  0,27...
► Artikel lesen
09.11.CSPC PHARMA Launches First Research Centers in China for Two Clinical Trials5
CSPC PHARMA Aktie jetzt für 0€ handeln
06.11.CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF SYH9061 FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS OFFICIALLY INITIATED ...3
06.11.CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - PHASE I/II CLINICAL TRIAL OF SYS6055 INJECTION FOR THE TREATMENT OF RELAPSED/REFRACTORY B-CELL NON-HODGKIN ...2
06.11.CSPC PHARMA (01093): DATE OF BOARD MEETING8
05.11.CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - PHASE I/II CLINICAL TRIAL OF SYS6062 FOR THE TREATMENT OF ADVANCED SOLID TUMOURS OFFICIALLY INITIATED AT ...5
04.11.CSPC PHARMA Launches First China Study Center for Clinical Trials of SYS6088 and SYH2072 Tablets4
03.11.CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - PHASE I/II CLINICAL TRIAL OF SYS6088 INJECTION FOR THE TREATMENT OF ADVANCED SOLID TUMOURS OFFICIALLY INITIATED ...3
03.11.CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF SYH2072 TABLETS FOR THE TREATMENT OF UNCONTROLLED HYPERTENSION AND RESISTANT ...2
03.11.CSPC PHARMA Launches Clinical Trials of SYS6057 and SYS6052 in China4
02.11.CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL TRIAL OF PRUSOGLIPTIN TABLETS IN COMBINATION WITH DAPAGLIFLOZIN TABLETS AND METFORMIN ...2
02.11.Citi: China Pharma and Biotech ESMO Data Further Validated; Favors CSPC PHARMA, HENGRUI PHARMA, INNOVENT BIO and SKB BIO13
02.11.CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - PHASE I/II CLINICAL TRIAL OF SYS6052 (RECOMBINANT HERPES ZOSTER VIRUS VACCINE (CHO CELLS)) OFFICIALLY INITIATED ...2
02.11.CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - PHASE I CLINICAL TRIAL OF SYS6057 (RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS VACCINE (CHO CELLS)) OFFICIALLY ...3
02.11.CSPC PHARMA Launches First China Center for Clinical Trial of SYS 6043 in Advanced Solid Tumors5
1 2 3 4 5 Weiter >>
131 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1